Spaulding Rehabilitation Hospital
spauldingrehab.orgTotal trials
111
Active
32
Phase 3
1
Total enrollment
4,251
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Buspirone Hydrochloride | — | — | — | — | — | 1 | |
| Buspirone placebo | — | — | — | — | — | 1 | |
| StrokeWear Motor and Behavioral Intervention | — | — | — | — | — | 1 | |
| MDMA | — | — | — | — | — | 1 | |
| Telmisartan, Metformin, Cilostazol | — | — | — | — | — | 1 |
Next readouts
- 2026-06-30
- 2026-07-31
- 2026-12
- 2027-10-31
Top conditions
- Stroke17
- Spinal Cord Injuries17
- Chronic Pain12
- Spinal Cord Injury7
- Traumatic Brain Injury5
- Fibromyalgia4
- Cerebral Palsy4
- Healthy4
Frequently asked questions about Spaulding Rehabilitation Hospital
- How many clinical trials does Spaulding Rehabilitation Hospital have on ClinicalTrials.gov?
- Spaulding Rehabilitation Hospital is listed as the lead sponsor on 111 clinical trials in ClinicalTrials.gov, 32 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Spaulding Rehabilitation Hospital's trials are in Phase 3?
- 1 of Spaulding Rehabilitation Hospital's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Spaulding Rehabilitation Hospital focus on?
- Spaulding Rehabilitation Hospital's most-studied conditions on ClinicalTrials.gov are Stroke, Spinal Cord Injuries, Chronic Pain, Spinal Cord Injury, Traumatic Brain Injury.
- When are Spaulding Rehabilitation Hospital's next clinical trial readouts?
- Spaulding Rehabilitation Hospital has 4 upcoming primary-completion readouts tracked here; the soonest is “Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors”, expected around 2026-06-30.